Navigation Links
GeneTex Antibody Company to Launch a Line of New Zebrafish Primary Antibodies
Date:6/28/2011

IRVINE, Calif., June 28, 2011 /PRNewswire/ -- GeneTex, a leading manufacturer of high quality antibodies, is pleased to announce that they will be launching a full line of zebrafish antibodies.

Zebrafish have been increasingly utilized as a model organism for scientific research. Due to their short lifecycles and relatively large clutch sizes, they are a useful model for genetic studies. Zebrafish eggs are externally fertilized; therefore, researchers can control and manipulate the embryos from the moment of fertilization. In addition, their embryos are transparent, so researchers are able to observe the changes that occur throughout the developmental stages of the embryo.

"We believe the zebrafish is an excellent model organism for biological research," said Dr. Kristina Beiswenger, Product Specialist at GeneTex, "however, this field has long been overlooked and lacks quality antibody reagents. GeneTex is fully committed to developing high quality antibodies specifically validated with zebrafish samples. We will continue to expand this product line to satisfy the needs of zebrafish research."

Many zebrafish tissues and organ systems, including the kidney, pancreas, bones and heart, are comparable to those of higher mammals and humans. The relatively large size, large number and external development of zebrafish embryos make them especially agreeable to manipulation by a variety of chemical, physical and genetic methods.

GeneTex is launching one of the largest collections of zebrafish antibodies that are validated for western blotting, immunofluorescence (ICC/IF), immunohistochemistry (IHC) and other applications. Almost all of the antibodies in the line are antigen-affinity purified, which results in higher quality antibodies.

For additional information on GeneTex's full line of zebrafish antibodies, call toll-free 877-GENETEX (436-3839) or visit

SOURCE GeneTex
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. DSM Biologics and MorphoSys AG to Manufacture Fully Human Antibody
2. Affitech and Omeros Enter Into Antibody Discovery and Development Agreement
3. ESBATech Announces Successful Completion of Phase I Clinical Study for Lead Antibody Fragment in Ophthalmic Indications
4. Takeda San Francisco, Inc. Appoints Gregory Landes, Ph.D. Vice President of Antibody Research
5. Affitech Announces Second Milestone in Roche Antibody Discovery Collaboration
6. SoluLinK Introduces New One-Shot ChromaLink(TM) Biotin Antibody Labeling Kit with Built-in Biotin Quantification.
7. Medarex and Massachusetts Biologic Laboratories Announce Primary Objective Achieved in Phase 2 Trial of Monoclonal Antibody Combination for the Treatment of Clostridium difficile Associated Diarrhea (CDAD)
8. InNexus Biotechnology Announces New EGFR Antibody DXL1218 Targeting Colorectal Cancer and Announces $1.25 Million Private Placement
9. PacificGMP and Actinium Pharmaceuticals Announce Agreements for cGMP Antibody Manufacturing and Stability Testing
10. MedImmune Advances Asthma Program With Start of Phase 2 Clinical Trial for Antibody Targeting IL-5 Receptor
11. BioWa Licenses POTELLIGENT(R) Technology to GlaxoSmithKline for Use in Antibody Development and Commercialization
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/25/2015)... , March 25, 2015  S&P Capital IQ ... Factual Stock Report coverage on Abattis Bioceuticals Corp ... CSE: ATT): is a specialty biotechnology company with ... licensing and marketing proprietary ingredients, bio-similar compounds, patented ... North America . The company ...
(Date:3/25/2015)... CAMBRIDGE, Mass. and REYKJAVIK, ... which provides comprehensive capabilities for using the genome to create ... their publication of the largest studies of whole-genome data yet ... in Nature Genetics – are built ... variation, authored by a team of deCODE scientists led by ...
(Date:3/25/2015)... 25, 2015 Data from Evidence ... of Action in Neuromuscular Diseases , South ... Incorporated (Nasdaq: CYTK) announced the publication of a ... activator tirasemtiv in the journal Neurotherapeutics. This ... of Effect” or hypothesis-generating clinical trial which evaluated ...
(Date:3/25/2015)... and the HAGUE, Netherlands ... two-year results of LES Stimulation therapy for chronic gastro-esophageal ... journal Surgery [ Surgery . 2015; ... of its minimally-invasive therapy. The study ... duration of 11 years and taking prescribed daily proton ...
Breaking Biology Technology:S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 5Landmark deCODE Studies Demonstrate the Power of Truly Big Genomics for Improving Medicine Worldwide 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 3Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 4Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 5Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 6EndoStim LES Stimulation therapy demonstrates long term safety and efficacy results in treating reflux patients 2EndoStim LES Stimulation therapy demonstrates long term safety and efficacy results in treating reflux patients 3
... Multiporator / Electroporator 2510 , , , , , , , ... Protocol No. 4308 915.509 12/2001 , , , ... , , Microorganism , ... Cell type , Bacteria, gram positive, , ...
... , , Multiporator / Electroporator 2510 , , , , , , ... Transformation Protocol , Protocol No. 4308 915.506 12/2001 , , ... , , Microorganism , ... Cell type , Bacteria, gram negative, ...
... , , , , , , Multiporator , , , ... Transfection Protocol , Protocol No. 4308 915.042 11/2001 , ... , , , , ... , Transfection with , Plasmid pEGFP-N1 (in bidistilled ...
Cached Biology Technology:Clostridium botulinum 2Borrelia burgdorferi 2B16 2
(Date:3/20/2015)... , Mar. 19, 2015 Research and Markets ... "Iris Biometrics - Global Strategic Business Report" report to ... for Iris Biometrics in US$ Thousands. The report provides separate ... Japan , Europe , ... , and Latin America . ...
(Date:3/17/2015)... Emotient, the leader in facial expression ... availability of Emotient Analytics , the world,s ... facial expressions. The system analyzes videos of people ... services. It delivers audience response metrics - such ... derived from facial evidence of emotional states. Consumer ...
(Date:3/12/2015)... , March 12, 2015 The mascots of ... Children,s Hospital, part of Wake Forest Baptist Medical Center. ... for the 2015 ACC Men,s Basketball Tournament. Young patients ... them and getting their autographs. Brenner Children,s ... It is the only children,s hospital in northwest ...
Breaking Biology News(10 mins):Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 2New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 3New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 4
... - One of the most common house ant species might ... spaces in a forest, but the ants have found ways ... Grzegorz Buczkowski, a Purdue University research assistant professor of entomology, ... complex as they move from forest to city and act ...
... -- Amphibiansfrogs, toads, salamanders, and newtsare disappearing worldwide, but ... be stable. This region is home to the largest ... species reside here), and scientists want to understand what ... research published in the March 29, 2010 issue of ...
... for a gene to create a protein, the gene,s DNA ... These RNA molecules are the instruction manuals that show the ... a protein. A few years ago, scientists studying bacterial cells ... can bind to. In doing so, they induce the RNA ...
Cached Biology News:Common house ants form supercolonies, prosper in urban settings 2Young salamanders' movement over land helps stabilize populations 2Young salamanders' movement over land helps stabilize populations 3Genes under control 2
... Automated Spot Picking,A modified digital scanner serves ... three of the five standard rack positions ... to 4 micro well plates on the ... selection of single spots by mouse-click on ...
... Features hardwall acrylic panels ... frame to form a free-standing ... to Class 10/ISO 3. Optional ... and ionizers are configured to ...
... Phosphate Sensor is a highly sensitive ... This product is a purified form of ... the fluorophore MDCC, which is sensitive to ... inorganic phosphate by Phosphate Sensor is rapid ...
Sigmas E-TOXATE (Limulus Amebocyte Lysate) test kits are intended for the detection and semiquantitation,of endotoxins for research purposes....
Biology Products: